Cargando…

CANNABIDIOL- PROVOKES OR TREATS ANXIETY DISORDERS?

INTRODUCTION: After the introduction of proposal regarding cannabidiol for the treatment of some psychiatric disorders including anxiety, there is confusion if cannabidiol use is associated with the provocation of anxiety symptoms or it can be safely used for the treatment. In nonmedical terms, (Can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arshad, H., Arshad, A., Khalid, M., Khan, A. R., Arain, F., Khatri, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661522/ http://dx.doi.org/10.1192/j.eurpsy.2023.1432

Ejemplares similares

Psychiatric Manifestations of Iron Deficiency Anemia-A Literature Review
por: Arshad, H., et al.
Publicado: (2023)

WHAT IS MORE DANGEROUS- SUICIDALITY IN EPILEPSY OR EPILEPSY AS A DISEASE? _A REVIEW
por: Arshad, H., et al.
Publicado: (2023)

Insular changes in autism spectrum disorder patients
por: Arshad, H., et al.
Publicado: (2023)

Cannabidiol Regulation of Learned Fear: Implications for Treating Anxiety-Related Disorders
por: Jurkus, Regimantas, et al.
Publicado: (2016)

Vocal music and brain plasticity_a literature review
por: Arshad, H., et al.
Publicado: (2023)

Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?
por: Peres, Fernanda F., et al.
Publicado: (2018)

Cannabidiol (CBD) and Insomnia : Literature review
por: Gutierrez Higueras, T., et al.
Publicado: (2022)

The influence of social anxiety-provoking contexts on context reinstatement effects
por: Yeung, Ryan C, et al.
Publicado: (2021)

In this study: Adapting to the new normal in COVID-19 pandemic; a global survey & literature review
por: Arain, F., et al.
Publicado: (2021)

13.2 CANNABIDIOL AS AN ANTIPSYCHOTIC DRUG
por: Guimaraes, Francisco, et al.
Publicado: (2018)

Anxiolytic Effects of Repeated Cannabidiol Treatment in Teenagers With Social Anxiety Disorders
por: Masataka, Nobuo
Publicado: (2019)

Do Stages of Dentistry Training Affect Anxiety Provoking Situations?
por: Obarisiagbon, A, et al.
Publicado: (2014)

Social anxiety provoked by speech-induced atrial tachycardia
por: Khemka, Abhishek, et al.
Publicado: (2015)

Positive Psychiatry: An Essential Tool to Treat Mental Health in the COVID-19 Era
por: Depa, N., et al.
Publicado: (2023)

Investigating Depression and Anxiety among Turkish Immigrants with Endocrine Disorders Treated at the NPZR
por: Cindik-Herbrüggen, E.D., et al.
Publicado: (2022)

Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders
por: García-Gutiérrez, María S., et al.
Publicado: (2020)

Pregabalin for the treatment of generalized anxiety disorder
por: Khallouk, A., et al.
Publicado: (2022)

Cannabidiol and Neurodevelopmental Disorders in Children
por: Kwan Cheung, Keith A., et al.
Publicado: (2021)

17.2 EFFICACY OF CANNABIDIOL IN THE TREATMENT OF EARLY PSYCHOSIS.
por: Ranganathan, Mohini, et al.
Publicado: (2018)

Stimulant induced Dermatological and Vascular Complications in patients with ADHD: A literature review
por: Arain, F., et al.
Publicado: (2022)

TELE-PSYCHOTHERAPY OF ANXIETY AND DEPRESSION DISORDERS
por: Lancia, I. S., et al.
Publicado: (2023)

17.1 A RANDOMIZED CONTROLLED TRIAL OF CANNABIDIOL IN SCHIZOPHRENIA
por: McGuire, Philip, et al.
Publicado: (2018)

Are anxiety disorders a prelude to delusional disorder? A systematic review
por: Pedrero, A. Alvarez, et al.
Publicado: (2021)

Time trends in treated incidence, sociodemographic risk factors and comorbidities: a Finnish nationwide study on anxiety disorders
por: Khanal, P., et al.
Publicado: (2022)

Illness anxiety disorder
por: Higueras, P. Hervias, et al.
Publicado: (2021)

Attitude towards psychological help in anxiety disorders
por: Vinogradova, M., et al.
Publicado: (2021)

Depression and anxiety disorders in chronic hemodialysis patients
por: Bouali, W., et al.
Publicado: (2021)

Anxiety disorders and eating disorder symptoms: The role of disgust sensitivity
por: Santarelli, G., et al.
Publicado: (2021)

Effects of cannabidiol on behavioral and psychological symptoms of vascular dementia: a randomized, double-blind, placebo-controlled trial.
por: Pessoa, R. M. D. P. P., et al.
Publicado: (2023)

17.4 POSSIBLE MECHANISMS INVOLVED IN THE ANTIPSYCHOTIC EFFECTS OF CANNABIDIOL (CBD)
por: Crippa, Jose Alexandre, et al.
Publicado: (2018)

17. CANNABIDIOL AS A TREATMENT IN DIFFERENT STAGES OF PSYCHOSIS- EFFICACY AND MECHANISMS
por: Bhattacharyya, Sagnik
Publicado: (2018)

Role of digital health in improving physical and mental well-being during COVID-19 pandemic
por: Arain, F., et al.
Publicado: (2021)

The role of anxiety and gender in anticipation and avoidance of naturalistic anxiety‐provoking experiences during adolescence: An ecological momentary assessment study
por: Smith, Ashley R., et al.
Publicado: (2022)

The enduring effects of adverse childhood experiences (ACES) on mood dysregulation in children: A literature review
por: Arain, F., et al.
Publicado: (2021)

Benzodiazepine Prescription for Anxiety Disorders Increase the Risk of Substance Use Disorders: A Retrospective Cohort Study
por: Sun, C.-F., et al.
Publicado: (2023)

Anxiety and depressive disorders Screening among Healthcare Professionals
por: Ayed, W., et al.
Publicado: (2023)

Fears and anxiety disorders in young children with autistic disorders
por: Kalinina, M., et al.
Publicado: (2023)

Childhood trauma and comorbid anxiety disorders in patients with bipolar disorder
por: Bougacha, D., et al.
Publicado: (2022)

Anxiety and depressive disorders in patients with Covid-19
por: Stolyarova, A., et al.
Publicado: (2023)

The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging study
por: Bloomfield, Michael A. P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0u2ijombaa46dkrbs61eka37a5